Close-up of a stethoscope on a spread U.S. $100 dollars bills. getty

From the passage of the One Big Beautiful Bill to CMS’s newly announced strategic direction , from executive orders on pharmaceutical pricing to ongoing scrutiny of PBMs, Medicaid and the 340B program, there’s no shortage of movement across the healthcare landscape. At first glance, these efforts may seem disconnected. Actually, they reflect a growing recognition of a system-wide problem: the incentives that govern our healthcare system are broken. Fixing them requires more than incremental change.

If we’re serious about delivering better health outcomes at lower cost, we must embrace a new business model, one that aligns incentives, promotes transparency and holds every stakeholder accountable for the value it

See Full Page